The FINANCIAL -- Osaka, Japan, September 30, 2011 – Takeda Pharmaceutical Company Limited
announced today that it has been selected for the second consecutive
year for the Dow Jones Sustainability Asia Pacific Index (DJSI Asia
Pacific), the Asia Pacific version of the Dow Jones Sustainability
Indexes (DJSI), which is one of the world’s premier indices for Socially
Responsible Investment (SRI).
Jointly compiled by Dow Jones & Company of the United States and Sustainable Asset Management (SAM) AG of Switzerland, DJSI is a leading SRI index which assesses and selects leading sustainability-driven companies in terms of economic, environmental, and social criteria, and serves as one of the most important indices for investors who take into consideration the corporate social responsibility (CSR) initiatives of each company. Specifically designed for companies in the developed Asia Pacific markets including Japan, the DJSI Asia Pacific has captured the 156 companies, including 79 Japanese companies, which are leading the way in terms of sustainability among the 600 companies in the region.
For inclusion in the DJSI Asia Pacific, SAM assesses companies based on questionnaire responses, annual reports, and other publications from each company. Takeda has been included in the DJSI Asia Pacific for the second consecutive year for its outstanding performance based on the three criteria above. In addition to DJSI Asia Pacific, Takeda has also been included in the FTSE4Good Global Index and Morningstar Socially Responsible Investment Index (MS-SRI), both of which are also benchmark SRI indexes.
As a pharmaceutical company that is related to the people’s lives, Takeda will remain committed to the fulfillment of its social responsibility as a global entity, with a view towards realizing its Mission of “striving towards better health for patients worldwide through leading innovation in medicine.”
Related Stories
